Avni Blotra

Ms. Avni Blotra

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 July 2022 in Toxins
Verified
Journal Article
Open access
PDF file
SBSiddharth Bhatia
Siddharth Bhatia
ABAvni Blotra
Avni Blotra
Karthikeyan VasudevanKarthikeyan Vasudevan
Karthikeyan Vasudevan
In India, polyvalent antivenom is the mainstay treatment for snakebite envenoming. Due to batch-to-batch variation in antivenom production, manufacturers have to estimate its efficacy at each stage of IgG purification using the median effective dose which involves 100–120 mice for each batch. There is an urgent need to replace the excessive use of animals in snake antivenom production using in vitro alternatives. We tested the efficacy of a single batch of polyvalent antivenom from VINS bioproducts limited on Echis carinatus venom collected from three different locations—Tamil Nadu (ECVTN), Goa (ECVGO) and Rajasthan (ECVRAJ)—using different in vitro assays. Firstly, size-exclusion chromatography (SEC-HPLC) was used to quantify antivenom–venom complexes to assess the binding efficiency of the antivenom. Secondly, clotting, proteolytic and PLA2 activity assays were performed to quantify the ability of the antivenom to neutralize venom effects. The use of both binding and functional assays allowed us to measure the efficacy of the antivenom, as they represent multiple impacts of snake envenomation. The response from the assays was recorded for different antivenom–venom ratios and the dose–response curves were plotted. Based on the parameters that explained the curves, the efficacy scores (ES) of antivenom were computed. The binding assay revealed that ECVTN had more antivenom–venom complexes formed compared to the other venoms. The capacity of antivenom to neutralize proteolytic and PLA2 effects was lowest against ECVRAJ. The mean efficacy score of antivenom against ECVTN was the greatest, which was expected, as ECVTN is mainly used by antivenom manufacturers. These findings pave a way for the development of in vitro alternatives in antivenom efficacy assessment.

27 November 2023 in Toxicon
Verified
Journal Article
Closed access
RYRafika Yasmin
Rafika Yasmin
STSusmita Thakur
Susmita Thakur
ABAvni Blotra
Avni Blotra
ASAlka Sahu
Alka Sahu
KVKarthikeyan Vasudevan
Karthikeyan Vasudevan
RDRobin Doley
Robin Doley


6 September 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
ABAvni Blotra
Avni Blotra
ASAnukrati Sharma
Anukrati Sharma
DSDivya Tej Sowpati
Divya Tej Sowpati
Karthikeyan VasudevanKarthikeyan Vasudevan
Karthikeyan Vasudevan
Echis carinatus is a widely distributed venomous snake in the Indian subcontinent. It is one of the “Big Four” snake species responsible for mortality and severe health complications caused by envenomations. Given the significance of the species for human health, we assembled and annotated the whole genome of E. carinatus . Using long reads for assembly and short reads for correction, we achieved a highly contiguous 1.57Gb assembly, with a contig N50 of 17.1 Mb and scaffold N50 of 23.5 Mb. We could map 96.58% of our reads back to the assembled genome, and Benchmarking Universal Single-Copy Orthologs (BUSCO) score of 97.4%, indicates near completeness. 48.59% of the genome had repeat elements. The predominant types of repeats include retrotransposons (LINEs, SINEs and LTR elements), DNA transposons and satellite DNA (SSRs). Additionally, we conducted a gene prediction analysis, identifying a total of 26,711 protein-coding genes. These genes included alternatively spliced products, leading to the prediction of 31,106 proteins, 77.6% of which were successfully annotated using Blastp and InterProScan . Out of the total predicted gene set, we identified 119 toxin-coding genes, crucial for venom toxin production in the species. The acquisition of toxin sequence-based information resulted in a valuable dataset of genes that are involved in venom production in E. carinatus . This dataset advances our understanding of the biological processes underlying venom production and lays the foundation for the development of new antivenom formulations.

21 January 2026 in Toxins
Verified
Journal Article
Open access
PDF file
AKAkhilesh Kumar
Akhilesh Kumar
ASAlka Sahu
Alka Sahu
MGMaya Gopalakrishnan
Maya Gopalakrishnan
ABAvni Blotra
Avni Blotra
VRVishal Kumar Rout
Vishal Kumar Rout
Karthikeyan VasudevanKarthikeyan Vasudevan
Karthikeyan Vasudevan
The saw-scaled viper Echis carinatus, one of the “Big Four” causes of snakebites in India, is found from Sri Lanka to eastern Iraq. To investigate clinical reports regarding the limited efficacy of Indian polyvalent antivenom (IPAV) against envenomation in Echis carinatus sochureki (ECS) in northwestern India, we obtained 22 snakes from three locations in Rajasthan and identified 148–174 toxin isoforms belonging to 21–25 toxin families in their venom using a bottom-up proteomics approach. All samples showed a high abundance of snake venom metalloproteinases (SVMPs), particularly SVMP class III. Other major components were phospholipases A2, L-amino-acid oxidases, snake venom serine proteases and snaclecs (C-type lectins). Variation in venom composition among locations in Rajasthan, compared to E. c. carinatus (ECC) from southern India, was primarily due to differences in the relative abundance of these toxin families. Recognition of all venom components by IPAV was poor at lower antivenom concentrations. Notably, SVMP classes II and III were poorly recognized at all venom-to-antivenom ratios in all ECS venoms, and a plasma clotting assay revealed poor neutralization of procoagulant activity. This collaborative study highlights the need for the development of regional antivenoms to effectively treat snakebites in northwestern India.